Reviewed by WANGYATAO·Last reviewed 2026-11-11·Medical disclaimer

In short

The 2025 China migraine patient guide explains recognizing migraine (pulsating, one-sided, with nausea/light sensitivity), trigger management, acute abortive treatment, and preventive therapy including new CGRP-targeted options.

What this guide covers: Recognizing migraine · Trigger and lifestyle management · Acute treatment · Prevention · For patients

Recognizing migraine

Migraine is a recurrent neurological headache—typically throbbing, often one-sided, lasting 4–72 hours, and worsened by activity with nausea and sensitivity to light or sound. Some people have aura (visual or sensory warning signs).

Trigger and lifestyle management

Common triggers include irregular sleep, skipped meals, stress, certain foods, and dehydration. Keeping a headache diary helps identify and reduce personal triggers; regular routines and exercise help.

Acute treatment

Mild attacks may respond to simple analgesics; moderate-to-severe attacks use triptans or gepants. Treatment works best taken early, and overuse (rebound) must be avoided.

Prevention

Frequent or disabling migraine warrants preventive therapy—older agents (beta-blockers, topiramate, antidepressants) and newer CGRP monoclonal antibodies or oral CGRP antagonists are now available in China.

For patients

If headaches are frequent or suddenly 'the worst ever,' or come with weakness or speech trouble, get urgent evaluation to rule out other causes.

Sources and further reading

One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.

General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.